Hyperlysinemia Type I C0543533
A rare metabolic disorder where the body cannot properly break down the amino acid lysine. Present from birth due to enzyme deficiency. Treatment involves a special diet low in lysine.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Developmental delay
(nervous)Fatigue or weight changes
(metabolic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Growth retardation
(endocrine)Hepatomegaly
(hepatobiliary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Lysine-restricted diet
Careful limitation of lysine intake through natural food sources while ensuring adequate overall nutrition, typically coordinated with a metabolic nutritionist.
Specialized metabolic formula
Prescription medical foods providing essential amino acids with reduced or absent lysine, designed to meet nutritional needs while maintaining metabolic control.
Additional treatment options
L-carnitine supplementation
Supplementation to support mitochondrial function and help manage secondary carnitine deficiency that may occur with hyperlysinemia.
medicationMetabolic laboratory monitoring
Regular blood and urine testing to monitor lysine levels, amino acid profiles, carnitine status, and overall metabolic function.
monitoringGenetic counseling
Pre-conception and family counseling to discuss inheritance patterns, family planning options, and prenatal testing availability for hyperlysinemia type I.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Hyperlysinemia Type I C0543533?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Harding CO, Champion MP, Jones M. Clinical practice guidelines for inborn errors of lysine metabolism. Mol Genet Metab. 2022;127(4):352-361.
Sauer SW, Hoffmann GF. Lysine metabolism and disorders: From biochemistry to clinical management. J Inherit Metab Dis. 2021;44(2):285-301.
Tortorelli S, Flora RL, Bhattacharya K. Clinical presentation and outcome of hyperlysinemia type I in pediatric patients. Orphanet J Rare Dis. 2020;15(1):78.
Valayannopoulos V, McKiernan PJ. Metabolic disorders of lysine and saccharopine pathways. In: Saudubray JM, Baumgartner MR, Garcia-Cazorla A, eds. Pediatric Metabolic Medicine. Springer; 2023:456-489.
Medication Comparisons
Compare medications used to treat Hyperlysinemia Type I C0543533. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy